FDA Regulation of OTC Drugs in the U.S

  • Speaker:NORMA SKOLNIK
  • Date: 6th March 2018 10:00 AM PST | 01:00 PM EST
  • Duration:60Min
  • Product Code:GRC-90250

$279

refer

Refer Friend's


Live Session - How it works

  • Username and Password will be emailed to you within 24 hours prior to the date of the webinar.
  • Presentation handouts in pdf format will be emailed to you along with the login instructions.
  • Login to the session by clicking on “Join the Meeting” in the instructions provided by email and then dial the number to connect to the meeting audio or use your Computer to connect to audio (Connect to the audio using your phone - Recommended). Please use the exact name and the email address you used at the time of registration to join the meeting.
  • Get answers to your questions through interactive Q&A sessions. The Q and A sessions are at the end of the meeting. The expert will complete his/ her presentation and then the phone lines will be open for the audience to discuss your questions. You can also type in your questions using Chat box in the meeting window.
  • Please let us know your thoughts and views at the end of the webinar, your valuable feedback will help us improve our Training programs.
  • Certificate of attendance is emailed to you within 6 working days from the date the webinar was completed. If you haven't received an email within 6 working days. Please email our support@grcts.com

Recorded Session - How it works

  • Login Information with Password to access the webinar recording will be emailed to you within 48 hours from the date the Live webinar was completed. The link to the recording is valid for 6 months.
  • Please click on the link to access the Recording and type in the password provided in the email.
  • Presentation and other handouts will be emailed to you in a pdf format.

Training CD/ USB - How it works

The order will be processed within 2 working days from the date the webinar was completed. The presentation and other handouts will be emailed to you in a pdf format if we are unable to attach them in the CD or USB.

(For more information about our products and services please contact our support team by email support@grcts.com or call us at +1 (248) 233-2049.)

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications. 

Description:

This webinar will cover laws and regulations for successful marketing and compliance of OTC Drugs in the USA. The presentation will provide an overview of FDA OTC Drug regulations with a focus on OTC Drug Labeling requirements. It will help the attendee understand basic regulatory requirements for marketing and labeling OTC drugs successfully in the USA.

Objectives of Topic:

  • To gain an understanding of current Regulatory requirements for marketing OTC drugs in the U.S.;
  • To understand what OTC drug claims & labeling comply with FDA regulations;
  • To learn OTC Drug Facts labeling requirements;
  • To learn about the importance of OTC Drug Monographs;
  • To cover FDA serious adverse event reporting rules that are required for OTC drugs in the U.S.

Areas Covered in the Session :

  • Key regulatory requirements for marketing OTC drugs in the U.S.;
  • FDA labeling requirements for OTC drugs;
  • What claims are appropriate for OTC drugs vs. those to avoid; Rx to OTC Switch drugs;
  • FDA’s changing views on enforcement;
  • Serious Adverse Event reporting for OTC drugs.
Instructor Profile:

Norma Skolnik has over 35 years of U.S. regulatory experience, starting in the pharmaceutical industry.  She was Associate Director of Regulatory Affairs at Lederle Laboratories in Pearl River, N.Y. and then became Associate Director of Regulatory Affairs at Lederle Consumer Health where she helped launch Centrum and Caltrate dietary supplements. 

When Lederle was acquired by Wyeth, she became Associate Director of Regulatory Affairs there, acquiring more experience in the Dietary Supplement and OTC drug fields.  She joined Warner-Lambert Consumer Health division in 1998 and became Assistant Director of Adams Regulatory Affairs.  In 2002 after Pfizer’s takeover of Warner-Lambert, she was promoted to Director of Regulatory Affairs for the Adams division.   Adams was acquired by Cadbury-Schweppes in 2003 and she served as Cadbury Adams’ Director of Regulatory Affairs for the Americas from 2003 until her retirement in 2008.

Norma earned a Bachelor’s degree in Biology from the University of Cincinnati and holds a Master’s degree from Pratt Institute in Brooklyn, New York. She's also done graduate work at Columbia University and Montclair State University. Today Norma works as a regulatory consultant to FDA regulated companies and to firms who wish to launch products in the U.S.A.

Available Options

Recording: Access the training Recording for 6 months from any location

$279

CD: Shipped within 2 working days

$379

5 Member Group: 5 can Attend Live Meeting Online from any location globally

$2,249

10 Member group: 10 can Attend Live Meeting Online from any location globally

$3,269
For discounts and offers call support

Related Products

Labelling of GMO’s in the USA

Labelling of GMO’s in the USA

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the recording of the webinar for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at support@grcts.com. Description: This event will offer an overview of the status of GMO’s/Genetically Engineered foods in the USA, how they are regulated by the FDA, FDA’s Biotechnology Policy and Consultation program, and GMO labeling regulations aro..

$269

Understanding the US FDA Drug Review and Approval Process

Understanding the US FDA Drug Review and Approval Process

We offer face to face in person seminar for companies/ corporate. Contact our support to set up a date and price. Why should you attend: The FDA’s Center for Drug Evaluation and Research (CDER) is responsible for reviewing and approving both prescription and nonprescription or over-the-counter (OTC) drugs. To introduce a new drug product into the U.S. market, some firms submit a new drug application (NDA) to the US FDA/CDER. The firms are responsible for testing a drug and for sub..

$279

U.S. Cosmetic Regulations and New Legislation

U.S. Cosmetic Regulations and New Legislation

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. You can access the recording of the webinar for 6 months. Contact our support for any clarifications.Description: This webinar will cover laws and regulations for successful marketing and compliance of cosmetics in the U.S. It will help clarify what claims and product labeling are appropriate for cosmetics to market them successfully and avoid regulatory issues and problems with FDA compliance and..

$269

Adverse event Reporting for Cosmetics ,OTC Drugs & Dietary Supplements

Adverse event Reporting for Cosmetics ,OTC Drugs & Dietary Supplements

Description: This webinar will cover laws and regulations for Adverse Event Reporting of OTC Drugs, Dietary Supplements & Cosmetics in the U.S.A.  The presentation will provide an understanding of FDA regulations to determine what are serious adverse events and how to report them properly. It will help the attendee understand current regulatory requirements for OTC Drug and Dietary Supplement adverse event reporting and what’s ahead for Cosmetic reporting in the U.S.A.Objectives of..

$269